Cargando…
Mechanisms of gefitinib-induced interstitial pneumonitis: why and how the TKI perturbs innate immune systems?
Autores principales: | Kagi, Tomohiro, Noguchi, Takuya, Matsuzawa, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238239/ https://www.ncbi.nlm.nih.gov/pubmed/34194630 http://dx.doi.org/10.18632/oncotarget.27958 |
Ejemplares similares
-
Gefitinib initiates sterile inflammation by promoting IL-1β and HMGB1 release via two distinct mechanisms
por: Noguchi, Takuya, et al.
Publicado: (2021) -
Why Target Innate Immune Cells in Cancers?
por: Poupot, Mary
Publicado: (2021) -
TAK1 Mediates ROS Generation Triggered by the Specific Cephalosporins through Noncanonical Mechanisms
por: Suzuki, Midori, et al.
Publicado: (2020) -
Docetaxel-related interstitial pneumonitis
por: Wang, Chung-Jen, et al.
Publicado: (2015) -
Bucillamine‐induced interstitial pneumonitis
por: Nakamoto, Keitaro, et al.
Publicado: (2018)